Copyright Reports & Markets. All rights reserved.

Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Allogeneic CAR T-Cells
    • 1.2.3 Autologous CAR T-Cells
  • 1.3 Market by Application
    • 1.3.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Hospital
    • 1.3.3 Diagnostic Center
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Perspective (2016-2027)
  • 2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Growth Trends by Regions
    • 2.2.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Share by Regions (2016-2021)
    • 2.2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Regions (2022-2027)
  • 2.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Industry Dynamic
    • 2.3.1 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Trends
    • 2.3.2 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Drivers
    • 2.3.3 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Challenges
    • 2.3.4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue
    • 3.1.1 Global Top Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Players by Revenue (2016-2021)
    • 3.1.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue Market Share by Players (2016-2021)
  • 3.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue
  • 3.4 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio
    • 3.4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Revenue in 2020
  • 3.5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Key Players Head office and Area Served
  • 3.6 Key Players Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Product Solution and Service
  • 3.7 Date of Enter into Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Type

  • 4.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Type (2016-2021)
  • 4.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

5 Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Breakdown Data by Application

  • 5.1 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Historic Market Size by Application (2016-2021)
  • 5.2 Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
  • 6.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
    • 6.2.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
    • 6.2.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
    • 6.2.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
  • 6.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
    • 6.3.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
    • 6.3.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
    • 6.3.3 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
  • 6.4 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
    • 6.4.1 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
    • 6.4.2 North America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
  • 7.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
    • 7.2.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
    • 7.2.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
    • 7.2.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
  • 7.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
    • 7.3.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
    • 7.3.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
    • 7.3.3 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
  • 7.4 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
    • 7.4.1 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
    • 7.4.2 Europe Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
  • 8.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
    • 8.2.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
    • 8.3.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region
    • 8.4.1 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
  • 9.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
    • 9.2.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
    • 9.2.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
    • 9.2.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
  • 9.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
    • 9.3.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
    • 9.3.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
    • 9.3.3 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
  • 9.4 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
    • 9.4.1 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
    • 9.4.2 Latin America Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size (2016-2027)
  • 10.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type
    • 10.2.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application
    • 10.3.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country
    • 10.4.1 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Details
    • 11.1.2 Pfizer Business Overview
    • 11.1.3 Pfizer Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.1.4 Pfizer Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.1.5 Pfizer Recent Development
  • 11.2 Novartis
    • 11.2.1 Novartis Company Details
    • 11.2.2 Novartis Business Overview
    • 11.2.3 Novartis Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.2.4 Novartis Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.2.5 Novartis Recent Development
  • 11.3 Bristol Myers Squibb
    • 11.3.1 Bristol Myers Squibb Company Details
    • 11.3.2 Bristol Myers Squibb Business Overview
    • 11.3.3 Bristol Myers Squibb Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.3.4 Bristol Myers Squibb Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.3.5 Bristol Myers Squibb Recent Development
  • 11.4 Legend Biotech
    • 11.4.1 Legend Biotech Company Details
    • 11.4.2 Legend Biotech Business Overview
    • 11.4.3 Legend Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.4.4 Legend Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.4.5 Legend Biotech Recent Development
  • 11.5 Sorrento Therapeutics
    • 11.5.1 Sorrento Therapeutics Company Details
    • 11.5.2 Sorrento Therapeutics Business Overview
    • 11.5.3 Sorrento Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.5.4 Sorrento Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.5.5 Sorrento Therapeutics Recent Development
  • 11.6 CARSGEN Therapeutics，Ltd
    • 11.6.1 CARSGEN Therapeutics，Ltd Company Details
    • 11.6.2 CARSGEN Therapeutics，Ltd Business Overview
    • 11.6.3 CARSGEN Therapeutics，Ltd Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.6.4 CARSGEN Therapeutics，Ltd Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.6.5 CARSGEN Therapeutics，Ltd Recent Development
  • 11.7 Juno Therapeutics
    • 11.7.1 Juno Therapeutics Company Details
    • 11.7.2 Juno Therapeutics Business Overview
    • 11.7.3 Juno Therapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.7.4 Juno Therapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.7.5 Juno Therapeutics Recent Development
  • 11.8 Kite Pharma
    • 11.8.1 Kite Pharma Company Details
    • 11.8.2 Kite Pharma Business Overview
    • 11.8.3 Kite Pharma Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.8.4 Kite Pharma Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.8.5 Kite Pharma Recent Development
  • 11.9 Atara Biotherapeutics
    • 11.9.1 Atara Biotherapeutics Company Details
    • 11.9.2 Atara Biotherapeutics Business Overview
    • 11.9.3 Atara Biotherapeutics Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.9.4 Atara Biotherapeutics Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.9.5 Atara Biotherapeutics Recent Development
  • 11.10 Carina Biotech
    • 11.10.1 Carina Biotech Company Details
    • 11.10.2 Carina Biotech Business Overview
    • 11.10.3 Carina Biotech Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.10.4 Carina Biotech Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.10.5 Carina Biotech Recent Development
  • 11.11 Guangzhou Xiangxue Pharmaceutical
    • 11.11.1 Guangzhou Xiangxue Pharmaceutical Company Details
    • 11.11.2 Guangzhou Xiangxue Pharmaceutical Business Overview
    • 11.11.3 Guangzhou Xiangxue Pharmaceutical Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Introduction
    • 11.11.4 Guangzhou Xiangxue Pharmaceutical Revenue in Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Business (2016-2021)
    • 11.11.5 Guangzhou Xiangxue Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy Scope and Market Size
    Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chimeric Antigen Receptor (CAR) T-Cell Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Allogeneic CAR T-Cells
    Autologous CAR T-Cells

    Segment by Application
    Hospital
    Diagnostic Center
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Pfizer
    Novartis
    Bristol Myers Squibb
    Legend Biotech
    Sorrento Therapeutics
    CARSGEN Therapeutics，Ltd
    Juno Therapeutics
    Kite Pharma
    Atara Biotherapeutics
    Carina Biotech
    Guangzhou Xiangxue Pharmaceutical

    Buy now